Literature DB >> 23509889

Acute lymphoblastic leukemia in early childhood as the presenting sign of ataxia-telangiectasia variant.

Bella Bielorai1, Tamar Fisher, Dalia Waldman, Yaniv Lerenthal, Andreea Nissenkorn, Tali Tohami, Dina Marek, Ninette Amariglio, Amos Toren.   

Abstract

Ataxia-telangiectasia (A-T), an autosomal recessive disorder is characterized by progressive neurodegeneration, immunodeficiency, sensitivity to ionizing radiation, and predisposition to cancer, especially to lymphoid malignancies. A-T variant is characterized by a milder clinical phenotype and is caused by missense or leaky splice site mutations that produce residual ataxia telangiectasia mutated (ATM) kinase activity. Lymphoid malignancy can precede the diagnosis of A-T, particularly in young children with mild neurological symptoms. We studied a consanguineous family with four A-T variant patients, three of them developed T-ALL at a young age before the diagnosis of A-T was established. ATM mutation analysis detected two new missense mutations both within exon 12: c.1514T>C and c.1547T>C. All four patients are homozygous for the two mutations, while their parents are heterozygous for the mutations. ATM protein level was low in all patients and the response to the radiomimetic agent, neocarzinostatin, was reduced. Leukemic presentation in a young age in three members of consanguineous family led to the identification of a new missense mutation in the ATM gene. The diagnosis of A-T or A-T variant should be considered in children with neurological abnormalities who develop T-ALL at a young age.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23509889     DOI: 10.3109/08880018.2013.777949

Source DB:  PubMed          Journal:  Pediatr Hematol Oncol        ISSN: 0888-0018            Impact factor:   1.969


  12 in total

1.  Genetic association with B-cell acute lymphoblastic leukemia in allogeneic transplant patients differs by age and sex.

Authors:  Alyssa I Clay-Gilmour; Theresa Hahn; Leah M Preus; Kenan Onel; Andrew Skol; Eric Hungate; Qianqian Zhu; Christopher A Haiman; Daniel O Stram; Loreall Pooler; Xin Sheng; Li Yan; Qian Liu; Qiang Hu; Song Liu; Sebastiano Battaglia; Xiaochun Zhu; AnneMarie W Block; Sheila N J Sait; Ezgi Karaesmen; Abbas Rizvi; Daniel J Weisdorf; Christine B Ambrosone; David Tritchler; Eva Ellinghaus; David Ellinghaus; Martin Stanulla; Jacqueline Clavel; Laurent Orsi; Stephen Spellman; Marcelo C Pasquini; Philip L McCarthy; Lara E Sucheston-Campbell
Journal:  Blood Adv       Date:  2017-09-08

2.  Endocrine abnormalities in ataxia telangiectasia: findings from a national cohort.

Authors:  Andreea Nissenkorn; Yael Levy-Shraga; Yonit Banet-Levi; Avishay Lahad; Ifat Sarouk; Dalit Modan-Moses
Journal:  Pediatr Res       Date:  2016-02-18       Impact factor: 3.756

Review 3.  Germline CHEK2 and ATM Variants in Myeloid and Other Hematopoietic Malignancies.

Authors:  Ryan J Stubbins; Sophia Korotev; Lucy A Godley
Journal:  Curr Hematol Malig Rep       Date:  2022-06-08       Impact factor: 4.213

Review 4.  Use of poly ADP-ribose polymerase [PARP] inhibitors in cancer cells bearing DDR defects: the rationale for their inclusion in the clinic.

Authors:  Aniello Cerrato; Francesco Morra; Angela Celetti
Journal:  J Exp Clin Cancer Res       Date:  2016-11-24

Review 5.  Ataxia telangiectasia: a review.

Authors:  Cynthia Rothblum-Oviatt; Jennifer Wright; Maureen A Lefton-Greif; Sharon A McGrath-Morrow; Thomas O Crawford; Howard M Lederman
Journal:  Orphanet J Rare Dis       Date:  2016-11-25       Impact factor: 4.123

Review 6.  Acute lymphoblastic leukemia: a comprehensive review and 2017 update.

Authors:  T Terwilliger; M Abdul-Hay
Journal:  Blood Cancer J       Date:  2017-06-30       Impact factor: 11.037

7.  A new ataxia-telangiectasia mutation in an 11-year-old female.

Authors:  Esmaeil Mortaz; Sayed Mehran Marashian; Hosseinali Ghaffaripour; Mohammad Varahram; Payam Mehrian; Atosa Dorudinia; Johan Garssen; Ian M Adcock; Malcolm Taylor; Seyed Alireza Mahdaviani
Journal:  Immunogenetics       Date:  2017-05-09       Impact factor: 2.846

8.  New diagnosis of atypical ataxia-telangiectasia in a 17-year-old boy with T-cell acute lymphoblastic leukemia and a novel ATM mutation.

Authors:  Jasmin Roohi; Jennifer Crowe; Denis Loredan; Kwame Anyane-Yeboa; Mahesh M Mansukhani; Lenore Omesi; Jennifer Levine; Anya Revah Politi; Shan Zha
Journal:  J Hum Genet       Date:  2017-01-26       Impact factor: 3.172

9.  Severe immunodeficiency associated with acute lymphoblastic leukemia and its treatment.

Authors:  Nikita Raje; Brenda L Snyder; David A Hill; Jenna L Streicher; Kate E Sullivan
Journal:  Ann Allergy Asthma Immunol       Date:  2018-03-19       Impact factor: 6.347

10.  Atypical Ataxia Presentation in Variant Ataxia Telangiectasia: Iranian Case-Series and Review of the Literature.

Authors:  Tannaz Moeini Shad; Reza Yazdani; Parisa Amirifar; Samaneh Delavari; Marzieh Heidarzadeh Arani; Seyed Alireza Mahdaviani; Mahnaz Sadeghi-Shabestari; Asghar Aghamohammadi; Nima Rezaei; Hassan Abolhassani
Journal:  Front Immunol       Date:  2022-01-14       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.